Document Details

leichnam

Uploaded by leichnam

Emory & Henry College

Tags

alzheimers disease dementia drugs cholinesterase inhibitors medicine

Summary

This document discusses various dementia drugs, including their mechanisms of action, side effects, and clinical considerations. It covers topics like cholinesterase inhibitors and NMDA blockers, and includes multiple-choice questions on the material.

Full Transcript

\#\#\# Slide 14 - Reversible Cholinesterase Inhibitors 1\. \*\*What is the primary mechanism of action of reversible cholinesterase inhibitors in Alzheimer's disease?\*\* \- A) Inhibiting dopamine reuptake \- B) Preventing the breakdown of acetylcholine in the synapse \- C) Enhancing GABA transm...

\#\#\# Slide 14 - Reversible Cholinesterase Inhibitors 1\. \*\*What is the primary mechanism of action of reversible cholinesterase inhibitors in Alzheimer's disease?\*\* \- A) Inhibiting dopamine reuptake \- B) Preventing the breakdown of acetylcholine in the synapse \- C) Enhancing GABA transmission \- D) Blocking NMDA receptors \*\*Answer\*\*: B) Preventing the breakdown of acetylcholine in the synapse 2\. \*\*Which reversible cholinesterase inhibitor was removed from the market due to hepatotoxicity?\*\* \- A) Donepezil \- B) Galantamine \- C) Rivastigmine \- D) Tacrine \*\*Answer\*\*: D) Tacrine 3\. \*\*What benefit does rivastigmine provide in treating Alzheimer's disease?\*\* \- A) Enhances dopamine release \- B) Delays cognitive impairment for at least 6 months \- C) Increases serotonin levels \- D) Reduces NMDA receptor activity \*\*Answer\*\*: B) Delays cognitive impairment for at least 6 months \#\#\# Slide 15 - Efficacy of Cholinesterase Inhibitors 4\. \*\*What is considered a significant change in the ADAS-Cog score when assessing Alzheimer\'s disease?\*\* \- A) A change of 1 point out of 100 \- B) A change of 4 points out of 70 \- C) A change of 10 points out of 50 \- D) A change of 5 points out of 30 \*\*Answer\*\*: B) A change of 4 points out of 70 5\. \*\*How do cholinesterase inhibitors affect the MMSE (Mini-Mental State Exam) score?\*\* \- A) Improve MMSE by 3 points \- B) Improve MMSE by 1 point \- C) Decrease MMSE by 2 points \- D) Have no impact on MMSE score \*\*Answer\*\*: B) Improve MMSE by 1 point 6\. \*\*What test is used to evaluate cognitive areas such as attention, orientation, and language in moderate to severe dementia?\*\* \- A) ADAS-Cog \- B) CIBIC \- C) MMSE \- D) SIB \*\*Answer\*\*: D) SIB \#\#\# Slide 16 - Cholinesterase Inhibitors and Side Effects 7\. \*\*What is a significant side effect associated with cholinesterase inhibitors?\*\* \- A) Tachycardia \- B) Bradycardia \- C) Hypertension \- D) Weight gain \*\*Answer\*\*: B) Bradycardia 8\. \*\*Which class of drugs can inhibit the beneficial effects of cholinesterase inhibitors in Alzheimer's patients?\*\* \- A) Dopamine agonists \- B) Anticholinergic drugs \- C) SSRIs \- D) MAO inhibitors \*\*Answer\*\*: B) Anticholinergic drugs 9\. \*\*Cholinesterase inhibitors can interact with which cytochrome P450 enzyme system?\*\* \- A) CYP3A4 \- B) CYP2D6 \- C) CYP1A2 \- D) CYP2C9 \*\*Answer\*\*: A) CYP3A4 \#\#\# Slide 17 - NMDA Blockers 10\. \*\*Memantine, used in Alzheimer's treatment, works by blocking which receptor?\*\* \- A) Dopamine \- B) NMDA \- C) Serotonin \- D) Acetylcholine \*\*Answer\*\*: B) NMDA 11\. \*\*Memantine is most beneficial in which stage of Alzheimer's disease?\*\* \- A) Early-stage \- B) Asymptomatic \- C) Moderate to severe \- D) Preclinical \*\*Answer\*\*: C) Moderate to severe 12\. \*\*What is a common side effect of NMDA blockers like memantine?\*\* \- A) Weight gain \- B) Dizziness \- C) Increased appetite \- D) Hyperactivity \*\*Answer\*\*: B) Dizziness \#\#\# Slide 18 - Clinical Tips 13\. \*\*In which situation should Alzheimer's medications be tapered off?\*\* \- A) Patient shows rapid improvement in cognitive function \- B) End of life care or side effects \- C) At the beginning of treatment \- D) When the patient has trouble swallowing food \*\*Answer\*\*: B) End of life care or side effects 14\. \*\*What is a reason to stop Alzheimer's medication in a patient?\*\* \- A) Significant improvement within 3 months \- B) Severe side effects or MMSE \< 10 \- C) Elevated serum creatinine levels \- D) Lack of side effects \*\*Answer\*\*: B) Severe side effects or MMSE \< 10 15\. \*\*If Alzheimer's medications show no desired effects after how many months should they be tapered off?\*\* \- A) 1 month \- B) 6 months \- C) 3 to 6 months \- D) 12 months \*\*Answer\*\*: C) 3 to 6 months

Use Quizgecko on...
Browser
Browser